title: [Sexual dysfunction in men treated for testicular cancer].
abstract: Patients treated for testicular cancer have a higher risk of ejaculatory, orgasmic and erectile dysfunctions compared with healthy males. The causality is not clear. In this paper we assess sexual dysfunction in the different treatment modalities based on primarily 1 meta-analysis and 11 original articles. During treatment, approximately 1/3 of patients experience one or more sexual dysfunctions. Only retroperitodineal surgery is significantly correlated with a specific sexual dysfunction, which is loss of ejaculation. Psychosexual causes seem to be important in the understanding of sexual dysfunctions in the aftermath of testicular-cancer treatment.
authors: Rigshospitalet, Psykiatrisk Klinik, afsnit 7421, København Ø. snohi@dadlnet.dk
authors: Susanne
authors: S
authors: Rosendal
authors: Ellids
authors: E
authors: Kristensen
authors: Annamaria G E
authors: AG
authors: Giraldi
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects; D003131:Combined Modality Therapy / Q000009:adverse effects; D007172:Erectile Dysfunction / Q000209:etiology; D006801:Humans; D007989:Libido; D008297:Male; D008875:Middle Aged; D009919:Orchiectomy / Q000009:adverse effects; D009948:Orgasm; D011878:Radiotherapy / Q000009:adverse effects; D012307:Risk Factors; D012735:Sexual Dysfunction, Physiological / Q000209:etiology*; D020018:Sexual Dysfunctions, Psychological / Q000209:etiology*; D013736:Testicular Neoplasms / Q000150:complications* / Q000523:psychology / Q000628:therapy
chemical_list: D000970:Antineoplastic Agents